Epididymal Macrophage Senescence Contributes to Sperm Motility Decrease upon Environmental Stress

A 170-man study linked urinary lead and cadmium to lower sperm motility; mouse work traced the mechanism to senescent immune cells in the epididymis.

Journal: Science Advances | Published: 2026-02-27 | Type: Journal Article | PMID: 41758944 Authors: Wang Xin-Run, Li Hao, Xiong Yong-Wei et al. — Department of Toxicology, Anhui Medical University Funding/COI: Funding not disclosed. Authors declare no competing interests.

Summary

This paper proposes a previously undescribed pathway connecting heavy metal exposure to reduced sperm motility: lead, cadmium, and mercury trigger cellular senescence in epididymal macrophages, which then flood the local environment with inflammatory signals that impair sperm. The human data is correlational and the sample is small, but the mechanistic chain — heavy metals → FTO inhibition → Foxo3 hypermethylation → macrophage senescence → SASP → motility loss — is laid out across human, mouse, and cell-culture experiments that largely tell a consistent story. Whether any of this translates to a treatable target in men is a long way off.

Claims

• In 170 men recruited from a single fertility clinic, urinary lead (β = −6.77, P = 0.007) and cadmium (β = −5.07, P = 0.028) were significantly and negatively associated with progressive sperm motility; mercury trended in the same direction (β = −8.36, P = 0.051) but did not clear the significance threshold
• Combined exposure to all three metals showed a significant negative effect on motility (β = −2.06, P = 0.001) by multiple linear regression and Bayesian kernel machine regression
• In C57BL/6J mice, combined Pb/Cd/Hg exposure reduced sperm motility and progressive motility, consistent with the human data
• Environmental stress reduced the total number of epididymal macrophages while increasing the proportion that were senescent; dendritic cells and monocytes were unaffected
• IL-6 — a key senescence-associated secretory phenotype (SASP) marker previously linked to lower sperm motility — was elevated in both exposed mouse epididymis tissue and RAW264.7 macrophages treated in vitro
• Clearing senescent epididymal macrophages (senolytics) in vivo significantly alleviated the heavy-metal-induced sperm motility reduction in mice
• The proposed mechanism: heavy metals increase N6-methyladenosine (m6A) modification on Foxo3 mRNA and inhibit FTO (the primary m6A demethylase), reducing Foxo3 protein expression and driving macrophage senescence
• FTO overexpression in vitro and S-adenosylhomocysteine (SAH) supplementation in vivo both attenuated macrophage senescence under heavy metal stress

Study Quality

The human component is a cross-sectional study enrolling 262 men between June and September 2023 at a single reproductive medicine center, with 170 ultimately included after exclusions. The use of multiple convergent statistical approaches (QGCOMP, restricted cubic splines, multiple linear regression with BMI and age as covariates, BKMR) strengthens the association finding, but cross-sectional design cannot establish causation — men with poor sperm motility from other causes may differ systematically in occupational exposure or lifestyle. Recruiting exclusively from a fertility clinic over three summer months introduces both selection bias (these men are already seeking care for reproductive issues) and potential seasonal exposure variability. The ICP-MS measurements are methodologically rigorous, with spiked recovery rates of 93–115% and appropriate quality controls.

The mechanistic work is conducted in mice and RAW264.7 macrophages (a murine cell line). The epididymal biology may not translate directly to humans. The senolytic clearance experiment in mice is the paper's strongest causal claim and its most interesting finding, but it uses a non-specific approach — any off-target effects of the senolytic agent on sperm or other epididymal cells are not fully excluded. Funding is not disclosed anywhere in the available text, which is a meaningful gap for a toxicology paper investigating industrial heavy metals.

Red Flags

• Cross-sectional design: association between urinary metals and motility cannot be interpreted as causal in humans
• n=170 from a single fertility clinic over three months — selection bias is substantial; these men are already presenting with reproductive concerns
• Mercury did not reach statistical significance (P = 0.051) but is included throughout as one of the "three key heavy metals"
• Funding source not listed; this matters for a paper on industrial pollutants
• All mechanistic work is in mice and a murine macrophage cell line — epididymal immune architecture differs between rodents and humans
• The senolytic intervention clears senescent cells broadly, not macrophage-specifically; confounding off-target effects are not ruled out
• SAH as an in vivo intervention is presented as a potential therapeutic direction based on mouse data alone

Strengths

• Human, animal, and cell-culture data all point in the same direction, lending coherence to the mechanistic hypothesis
• Multiple statistical models applied to the human dataset, with consistent results across methods
• ICP-MS quantification is rigorous with appropriate quality controls and blank corrections
• Identifies a specific molecular mechanism (FTO/m6A/Foxo3) rather than stopping at the phenotypic observation
• Senolytic rescue experiment provides the closest thing to a causal test in the mouse model
• Published in Science Advances, with peer review

Verdict

This paper earns attention for the mechanistic novelty: epididymal macrophage senescence as a driver of sperm motility loss is a genuinely new framing, and the FTO/Foxo3/m6A axis is a specific and testable claim. The human data, however, is weak scaffolding for that mechanism — 170 men, one clinic, cross-sectional, summer only, funding undisclosed. The mouse and cell-culture work does the heavy lifting, and rodent epididymal immunology is not a reliable proxy for the human situation. File this as hypothesis-generating preclinical research with a thin human correlate. It would take a prospective cohort study with longitudinal metal exposure tracking and a mechanistically targeted intervention to know whether any of this matters clinically.